Form 4: BeiGene Executive Sells Shares
Insider Transaction (Form 4)
Chan Henry Lee, SVP, General Counsel of BeiGene, Ltd., sold 1,115 shares of common stock on September 30, 2026 for $375.00 per share.
Summary
- Open-market sale: disposed of 1,115 American Depositary Shares at $375.00 ($418,125) on September 30, 2026 (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $418,125 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Chan Henry Lee — Officer (SVP, General Counsel)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-30 | Open-market sale | American Depositary Shares | 1,115 | $375 | $418.1K | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-30 | Open-market sale (1,115 shares) |
Keywords
insider transaction, Form 4, ONC, BeOne Medicines Ltd., bearish, Chan Henry Lee
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.